Design and development of novel mitochondrial targeted nanocarriers, dqasomes for curcumin inhalation

Molecular Pharmaceutics

Volumn 11, Issue 7, 2014, Pages 2334-2345

  Zupančič, Špela ^a   Kocbek, Petra ^a   Zariwala, M Gulrez ^b   Renshaw, Derek ^b   Gul, Mine Orlu ^c   Elsaid, Zeeneh ^c   Taylor, Kevin M G ^c   Somavarapu, Satyanarayana ^c  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY OF WESTMINSTER   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

acute lung injury; antioxidant; curcumin; DQAsomes; nebulization

Indexed keywords

AMPHOPHILE; CURCUMIN; DEQUALINIUM; DQASOME; NANOCARRIER; UNCLASSIFIED DRUG; DRUG CARRIER; NANOPARTICLE;

ANTIOXIDANT ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CACO 2 CELL LINE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG TARGETING; EPITHELIUM CELL; FREEZE DRYING; HUMAN; HUMAN CELL; HYDRODYNAMICS; HYDROGEN BOND; IN VITRO STUDY; INFRARED SPECTROSCOPY; MITOCHONDRION; MOLECULAR INTERACTION; NANOENCAPSULATION; NEBULIZATION; PRIORITY JOURNAL; X RAY DIFFRACTION; CHEMISTRY; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION; MEDICINAL CHEMISTRY; PARTICLE SIZE; PROCEDURES; SOLUBILITY;

ADMINISTRATION, INHALATION; CHEMISTRY, PHARMACEUTICAL; CURCUMIN; DEQUALINIUM; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; MITOCHONDRIA; NANOPARTICLES; PARTICLE SIZE; SOLUBILITY; X-RAY DIFFRACTION;

EID: 84904015499     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp500003q     Document Type: Article

References (66)

1. Bernard, G. R.; Artigas, A.; Brigham, K. L.; Carlet, J.; Falke, K.; Hudson, L.; Lamy, M.; Legall, J. R.; Morris, A.; Spragg, R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination Am. J. Respir. Crit. Care. Med. 1994, 149 (3 Pt 1) 818-24
2. Galani, V.; Tatsaki, E.; Bai, M.; Kitsoulis, P.; Lekka, M.; Nakos, G.; Kanavaros, P. The role of apoptosis in the pathophysiology of Acute Respiratory Distress Syndrome (ARDS): an up-to-date cell-specific review Pathol. Res. Pract. 2010, 206 (3) 145-50
3. Matthay, M. A.; Zemans, R. L. The acute respiratory distress syndrome: pathogenesis and treatment Annu. Rev. Pathol. 2011, 6, 147-63
4. Johnson, E. R.; Matthay, M. A. Acute lung injury: epidemiology, pathogenesis, and treatment J. Aerosol. Med. Pulm. Drug. Delivery 2010, 23 (4) 243-52
5. Maron-Gutierrez, T.; Silva, J. D.; Asensi, K. D.; Bakker-Abreu, I.; Shan, Y.; Diaz, B. L.; Goldenberg, R. C.; Mei, S. H.; Stewart, D. J.; Morales, M. M.; Rocco, P. R.; Dos Santos, C. C. Effects of mesenchymal stem cell therapy on the time course of pulmonary remodeling depend on the etiology of lung injury in mice Crit. Care Med. 2013, 41 (11) e319-33
6. Lim, S. B.; Rubinstein, I.; Sadikot, R. T.; Artwohl, J. E.; Onyuksel, H. A novel peptide nanomedicine against acute lung injury: GLP-1 in phospholipid micelles Pharm. Res. 2011, 28 (3) 662-72
7. Melo, A. C.; Valenca, S. S.; Gitirana, L. B.; Santos, J. C.; Ribeiro, M. L.; Machado, M. N.; Magalhaes, C. B.; Zin, W. A.; Porto, L. C. Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury Int. Immunopharmacol. 2013, 17 (1) 57-64
8. Xu, F.; Lin, S. H.; Yang, Y. Z.; Guo, R.; Cao, J.; Liu, Q. The effect of curcumin on sepsis-induced acute lung injury in a rat model through the inhibition of the TGF-beta1/SMAD3 pathway Int. Immunopharmacol. 2013, 16 (1) 1-6
9. Guzel, A.; Kanter, M.; Aksu, B.; Basaran, U. N.; Yalcin, O.; Guzel, A.; Uzun, H.; Konukoglu, D.; Karasalihoglu, S. Preventive effects of curcumin on different aspiration material-induced lung injury in rats Pediatr. Surg. Int. 2009, 25 (1) 83-92
10. Gunaydin, M.; Guzel, A.; Guzel, A.; Alacam, H.; Salis, O.; Murat, N.; Gacar, A.; Guvenc, T. The effect of curcumin on lung injuries in a rat model induced by aspirating gastrointestinal decontamination agents J. Pediatr. Surg. 2012, 47 (9) 1669-76
11. Xiao, X.; Yang, M.; Sun, D.; Sun, S. Curcumin protects against sepsis-induced acute lung injury in rats J. Surg. Res. 2012, 176 (1) e31-9
12. Nagpal, M.; Sood, S. Role of curcumin in systemic and oral health: An overview J. Nat. Sci. Biol. Med. 2013, 4 (1) 3-7
13. Beck-Broichsitter, M.; Merkel, O. M.; Kissel, T. Controlled pulmonary drug and gene delivery using polymeric nano-carriers J. Controlled Release 2012, 161 (2) 214-24
14. Sandersen, C.; Olejnik, D.; Franck, T.; Neven, P.; Serteyn, D.; Art, T. Inhalation with NDS27 attenuates pulmonary neutrophilic inflammation in recurrent airway obstruction Vet. Rec. 2011, 169 (4) 100
15. El-Sherbiny, I. M.; Smyth, H. D. Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles Mol. Pharmaceutics 2012, 9 (2) 269-80
16. Weissig, V.; Lasch, J.; Erdos, G.; Meyer, H. W.; Rowe, T. C.; Hughes, J. DQAsomes: a novel potential drug and gene delivery system made from Dequalinium Pharm. Res. 1998, 15 (2) 334-7
17. Lyrawati, D.; Trounson, A.; Cram, D. Expression of GFP in the mitochondrial compartment using DQAsome-mediated delivery of an artificial mini-mitochondrial genome Pharm. Res. 2011, 28 (11) 2848-62
18. DSouza, G. G.; Cheng, S. M.; Boddapati, S. V.; Horobin, R. W.; Weissig, V. Nanocarrier-assisted sub-cellular targeting to the site of mitochondria improves the pro-apoptotic activity of paclitaxel J. Drug Target 2008, 16 (7) 578-85
19. International Conference on Harmonization (ICH), Q2(R1):Validation of analytical procedures: text and methodology. RetrievedNovember 6, (2005.
20. Reviewer Guidance, Validation of Chromatographic Methods. Center for Drug Evaluation and Research, US Food and Drug Administration: 1994.
21. Zhang, X.; Jackson, J. K.; Burt, H. M. Determination of surfactant critical micelle concentration by a novel fluorescence depolarization technique J. Biochem. Biophys. Methods 1996) 31 (3-4) 145-50
22. Kalyanasundaram, K.; Thomas, J. K. Environmental effects on vibronic band intensities in pyrene monomer fluorescence and their application in studies of micellar systems J. Am. Chem. Soc. 1977, 99 (7) 2039-2044
23. Sessa, M.; Tsao, R.; Liu, R.; Ferrari, G.; Donsi, F. Evaluation of the stability and antioxidant activity of nanoencapsulated resveratrol during in vitro digestion J. Agric. Food Chem. 2011, 59 (23) 12352-60
24. 2.9.18. Preparations for Inhalation: Aerodynamic Assessment of Fine Particles. In: European pharmacopoeia 7.0; Council of Europe, European Directorate for the Quality of Medicines & HealthCare: Strasbourg, 2010,: pp 274-75.
25. Lukyanov, A. N.; Gao, Z.; Mazzola, L.; Torchilin, V. P. Polyethylene glycol-diacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice Pharm. Res. 2002, 19 (10) 1424-9
26. Tonnesen, H. H.; Masson, M.; Loftsson, T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability Int. J. Pharm. 2002, 244 (1-2) 127-35
27. Yang, R.; Zhang, S.; Kong, D.; Gao, X.; Zhao, Y.; Wang, Z. Biodegradable polymer-curcumin conjugate micelles enhance the loading and delivery of low-potency curcumin Pharm. Res. 2012, 29 (12) 3512-25
28. Gou, M.; Men, K.; Shi, H.; Xiang, M.; Zhang, J.; Song, J.; Long, J.; Wan, Y.; Luo, F.; Zhao, X.; Qian, Z. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo Nanoscale 2011, 3 (4) 1558-67
29. Vaidya, B.; Vyas, S. P. Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: development and characterization J. Drug Target. 2012, 20 (4) 372-80
30. Attwood, D.; Natarajan, R. Micellar properties and surface activity of some bolaform drugs in aqueous solution J. Pharm. Pharmacol. 1980, 32 (7) 460-2
31. Vaidya, B.; Paliwal, R.; Rai, S.; Khatri, K.; Goyal, A. K.; Mishra, N.; Vyas, S. P. Cell-selective mitochondrial targeting: A new approach for cancer therapy Cancer Therapy 2009, 7, 141-148
32. Mohan, P. R. K.; Sreelakshmi, G.; Muraleedharan, C. V.; Joseph, R. Water soluble complexes of curcumin with cyclodextrins: Characterization by FT-Raman spectroscopy Vib. Spectrosc. 2012, 62 (0) 77-84
33. Mohanty, C.; Sahoo, S. K. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation Biomaterials 2010, 31 (25) 6597-611
34. Yen, F. L.; Wu, T. H.; Tzeng, C. W.; Lin, L. T.; Lin, C. C. Curcumin nanoparticles improve the physicochemical properties of curcumin and effectively enhance its antioxidant and antihepatoma activities J. Agric. Food Chem. 2010, 58 (12) 7376-82
35. Hegge, A. B.; Vukicevic, M.; Bruzell, E.; Kristensen, S.; Tonnesen, H. H. Solid dispersions for preparation of phototoxic supersaturated solutions for antimicrobial photodynamic therapy (aPDT): Studies on curcumin and curcuminoides L Eur. J. Pharm. Biopharm. 2013, 83 (1) 95-105
36. Bourassa, P.; Kanakis, C. D.; Tarantilis, P.; Pollissiou, M. G.; Tajmir-Riahi, H. A. Resveratrol, genistein, and curcumin bind bovine serum albumin J. Phys. Chem. B 2010, 114 (9) 3348-54
37. Li, B.; Konecke, S.; Wegiel, L. A.; Taylor, L. S.; Edgar, K. J. Both solubility and chemical stability of curcumin are enhanced by solid dispersion in cellulose derivative matrices Carbohydr. Polym. 2013, 98 (1) 1108-16
38. Kolev, T. M.; Velcheva, E. A.; Stamboliyska, B. A.; Spiteller, M. DFT and experimental studies of the structure and vibrational spectra of curcumin Int. J. Quantum Chem. 2005, 102 (6) 1069-1079
39. Hung, W. C.; Chen, F. Y.; Lee, C. C.; Sun, Y.; Lee, M. T.; Huang, H. W. Membrane-thinning effect of curcumin Biophys. J. 2008, 94 (11) 4331-8
40. Perrie, Y. Pharmaceutical nanotechnology and nanomedicines. In Aultons pharmaceutics: the design and manufacture of medicines, 4 th ed.; Aulton, M. E.; Taylor, K., Eds.; Churchill Livingstone/Elsevier: Edinburgh, 2013; pp 777-96.
41. Weissig, V. From serendipity to mitochondria-targeted nanocarriers Pharm. Res. 2011, 28 (11) 2657-68
42. Barry, J.; Fritz, M.; Brender, J. R.; Smith, P. E.; Lee, D. K.; Ramamoorthy, A. Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin J. Am. Chem. Soc. 2009, 131 (12) 4490-8
43. Wang, Z.; Leung, M. H.; Kee, T. W.; English, D. S. The role of charge in the surfactant-assisted stabilization of the natural product curcumin Langmuir 2010, 26 (8) 5520-6
44. Adhikary, R.; Carlson, P. J.; Kee, T. W.; Petrich, J. W. Excited-state intramolecular hydrogen atom transfer of curcumin in surfactant micelles J. Phys. Chem. B 2010, 114 (8) 2997-3004
45. Halvorsen, B. L.; Blomhoff, R. Validation of a quantitative assay for the total content of lipophilic and hydrophilic antioxidants in foods Food Chem. 2011, 127 (2) 761-8
46. Sonkaew, P.; Sane, A.; Suppakul, P. Antioxidant activities of curcumin and ascorbyl dipalmitate nanoparticles and their activities after incorporation into cellulose-based packaging films J. Agric. Food. Chem. 2012, 60 (21) 5388-99
47. Weber, W. M.; Hunsaker, L. A.; Abcouwer, S. F.; Deck, L. M.; Vander Jagt, D. L. Anti-oxidant activities of curcumin and related enones Bioorg. Med. Chem. 2005, 13 (11) 3811-20
48. Benzie, I. F.; Strain, J. J. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: the FRAP assay Anal. Biochem. 1996, 239 (1) 70-6
49. Chaniyilparampu, R. N.; Nair, A. K.; Parthasarathy, K.; Gokaraju, G. R.; Gokaraju, R. R.; Bhupathiraju, K.; Mandapati, V. N. S. R. R.; Somashekara, N. Curcuminoids and its metabolites for the application in allergic ocular/nasal conditions. Patent US 20120010297 A1, 2012.
50. Kristl, J.; Volk, B.; Gasperlin, M.; Sentjurc, M.; Jurkovic, P. Effect of colloidal carriers on ascorbyl palmitate stability Eur. J. Pharm. Sci. 2003, 19 (4) 181-9
51. Ke, D.; Wang, X.; Yang, Q.; Niu, Y.; Chai, S.; Chen, Z.; An, X.; Shen, W. Spectrometric study on the interaction of dodecyltrimethylammonium bromide with curcumin Langmuir 2011, 27 (23) 14112-7
52. Kakran, M.; Sahoo, N. G.; Tan, I. L.; Li, L. Preparation of nanoparticles of poorly water-soluble antioxidant curcumin by antisolvent precipitation methods J. Nanopart. Res. 2012, 14 (3) 1-11
53. Abu-Dahab, R.; Schafer, U. F.; Lehr, C. M. Lectin-functionalized liposomes for pulmonary drug delivery: effect of nebulization on stability and bioadhesion Eur. J. Pharm. Sci. 2001, 14 (1) 37-46
54. Bridges, P. A.; Taylor, K. M. G. Nebulisers for the generation of liposomal aerosols Int. J. Pharm. 1998, 173 (1-2) 117-125
55. Zaru, M.; Mourtas, S.; Klepetsanis, P.; Fadda, A. M.; Antimisiaris, S. G. Liposomes for drug delivery to the lungs by nebulization Eur. J. Pharm. Biopharm. 2007, 67 (3) 655-66
56. Desai, T. R.; Hancock, R. E.; Finlay, W. H. A facile method of delivery of liposomes by nebulization J. Controlled Release 2002, 84 (1-2) 69-78
57. Dailey, L. A.; Schmehl, T.; Gessler, T.; Wittmar, M.; Grimminger, F.; Seeger, W.; Kissel, T. Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features J. Controlled Release 2003, 86 (1) 131-44
58. Chattopadhyay, S.; Ehrman, S. H.; Bellare, J.; Venkataraman, C. Morphology and bilayer integrity of small liposomes during aerosol generation by air-jet nebulisation J. Nanopart. Res. 2012, 14 (4) 1-15
59. Chattopadhyay, S.; Ehrman, S.; Bellare, J.; Venkataraman, C. Morphology and bilayer integrity of small liposomes during aerosol generation by air-jet nebulisation J. Nanopart. Res. 2012, 14 (4) 1-15
60. Johansson, F.; Hjertberg, E.; Eirefelt, S.; Tronde, A.; Hultkvist Bengtsson, U. Mechanisms for absorption enhancement of inhaled insulin by sodium taurocholate Eur. J. Pharm. Sci. 2002, 17 (1-2) 63-71
61. Tronde, A.; Krondahl, E.; von Euler-Chelpin, H.; Brunmark, P.; Bengtsson, U. H.; Ekstrom, G.; Lennernas, H. High airway-to-blood transport of an opioid tetrapeptide in the isolated rat lung after aerosol delivery Peptides 2002, 23 (3) 469-78
62. Ma, Z.; Lim, L.-Y. Uptake of Chitosan and Associated Insulin in Caco-2 Cell Monolayers: A Comparison Between Chitosan Molecules and Chitosan Nanoparticles Pharm. Res. 2003, 20 (11) 1812-1819
63. Huang, M.; Ma, Z.; Khor, E.; Lim, L. Y. Uptake of FITC-chitosan nanoparticles by A549 cells Pharm. Res. 2002, 19 (10) 1488-94
64. Marrache, S.; Dhar, S. Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics Proc. Natl. Acad. Sci. U S A 2012, 109 (40) 16288-93
65. Schumacker, P. T. Lung cell hypoxia: role of mitochondrial reactive oxygen species signaling in triggering responses Proc. Am. Thorac. Soc. 2011, 8 (6) 477-84
66. Li, X.; Fang, P.; Mai, J.; Choi, E. T.; Wang, H.; Yang, X. F. Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers J. Hematol. Oncol. 2013, 6, 19